Investor Backing & Capital Strength:
Investor backing is described as robust, including $125M in financing from Vista Credit Partners (2023) and a majority stake by Nordic Capital (2025) to fund product, hiring, and partnerships. These moves are presented as enabling continued expansion and R&D.
Innovation-Driven Growth:
Product momentum is evident through a next‑generation lakehouse data platform launched in February 2024 and subsequent AI‑enabled solutions for interoperability, network modeling, and precision medicine (2024–2026). CareJourney‑infused capabilities and an active platform roadmap signal an innovation‑led path to growth.
Market Expansion:
Market reach appears to be widening, with more than 2.25 million additional value‑based lives, an ecosystem exceeding 170 million clinical patient records, and hundreds of provider, payer, government, and life sciences customers cited. Entry into life sciences via data marketplace listings further broadens addressable demand.
